Search Results

Disclosure Ref 2025118 - Temporary Staffing data request.pdf

FOI Disclosure Ref 2025118 relating to temporary Staffing data request including shifts filled by bank and agency, procurement framework, spend etc

Disclosure Ref 2025115 - Patients with anxiety disorders 2021 to 2024.pdf

FOI disclosure Ref 2025115 relating to the number of attendances at DCHS UTCs with presenting complaint of anxiety disorders 2021 to 2024

Disclosure Ref 2025147 - Framework are you associated with for Sterile Service agency.pdf

FOI Disclosure Ref 2025147 regarding the Framework associated for Sterile Service agency

Appendix 5 Guidance Document When Shortlisting and Interviewing an At-Risk Candidate(s).docx

Disclosure Ref 2025191 - Contact details for Decontamination & Infection Control leads .pdf

FOI disclosure relating to contact details for DCHS Decontamination Lead, Infection Control Lead, Endoscopy Decontamination Manager and Estates Manager

Disclosure Ref 2024228 - Cost of specialist bariatric equipment.pdf

Freedom of information disclosure relating to spend on specialist bariatric equipment for obese/bariatric patients (patients over 160kg) during the last three financial years and a breakdown of the type of equipment used by the trust and the amounts spent, split between Rental expenditure and Purchased Equipment

Disclosure Ref 2024284 - Medication chain disruptions & incidents.pdf

Freedom of information disclosure relating to medication chain disruptions & incidents due to this

Dressing Formulary and Wound Care Guidelines (G68)

The Derbyshire Wound Care and dressing formulary has been revised in collaboration with the East Midlands Wound Care Formulary Group. Work has been undertaken to provide a clinically effective, appropriate and cost effective choices of products to manage the vast majority of wounds. The formulary is available for all practitioners working for Derbyshire Community Health Services and Primary Care Services. It is expected that prescribers will preferentially use the products listed in the guide for routine use and be able to provide robust rationale where they have prescribed outside the formulary.

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

Ward-Decoration-Guidelines.docx

Christmas 2021 - IP&C guidance